2023
DOI: 10.3389/fbioe.2023.1143157
|View full text |Cite
|
Sign up to set email alerts
|

Off-target effects in CRISPR/Cas9 gene editing

Abstract: Gene editing stands for the methods to precisely make changes to a specific nucleic acid sequence. With the recent development of the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system, gene editing has become efficient, convenient and programmable, leading to promising translational studies and clinical trials for both genetic and non-genetic diseases. A major concern in the applications of the CRISPR/Cas9 system is about its off-target effects, namely the deposition of unexpected,… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
82
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 152 publications
(83 citation statements)
references
References 109 publications
0
82
0
1
Order By: Relevance
“…We suspect that adaptive changes in gene expression may have occurred during clonal isolation of the Pum knockout cells that buffer the loss of Pum activity. We also found evidence of residual Cas9 expression in these cells, which could contribute to off-target effects (Guo et al 2023). For future analysis of regulated mRNA decay, a rapid, efficient, and transient means of depletion of a regulatory protein would be ideal, such as conditional degrons.…”
Section: Discussionmentioning
confidence: 74%
“…We suspect that adaptive changes in gene expression may have occurred during clonal isolation of the Pum knockout cells that buffer the loss of Pum activity. We also found evidence of residual Cas9 expression in these cells, which could contribute to off-target effects (Guo et al 2023). For future analysis of regulated mRNA decay, a rapid, efficient, and transient means of depletion of a regulatory protein would be ideal, such as conditional degrons.…”
Section: Discussionmentioning
confidence: 74%
“…The Cas9 nuclease from S. pyogenes was chosen as it is the most widely employed nuclease for genome editing using CRISPR (44, 45) and recognizes an NGG PAM (46, 47), which has been reported to hold the highest activity when compared to other PAMs (48-50). However, the specificity of CRISPR elements, such as the sgRNA towards the target site is not ensured; hence, the protospacer region of the sgRNA could anchor to other sites instead of its target, leading to unintended editing by off-target effects (51, 52).…”
Section: Resultsmentioning
confidence: 99%
“…131−133 Off-target effects occur when the Cas9 enzyme, guided by a single-guide RNA (sgRNA) molecule to a specific target gene, mistakenly edits similar, but not identical, sequences elsewhere in the genome. 134,135 This can lead to unintended genetic changes, potentially disrupting other important genes and causing unexpected consequences. 136,137 Sugar beet genomes are complex, with a large number of repetitive sequences and closely related genes.…”
Section: Limitations Of Crispr/cas Systems For Disease Resistance Dev...mentioning
confidence: 99%
“…Additionally, the fitness cost associated with targeting S genes can vary depending on factors such as disease susceptibility facilitators, defense suppressors, and genes or factors involved in the replication machinery. Another significant limitation is the issue of off-target effects. Off-target effects occur when the Cas9 enzyme, guided by a single-guide RNA (sgRNA) molecule to a specific target gene, mistakenly edits similar, but not identical, sequences elsewhere in the genome. , This can lead to unintended genetic changes, potentially disrupting other important genes and causing unexpected consequences. , Sugar beet genomes are complex, with a large number of repetitive sequences and closely related genes. This complexity increases the likelihood of off-target effects, as the CRISPR-Cas9 system might inadvertently target similar sequences elsewhere in the genome.…”
Section: Limitations Of Crispr/cas Systems For Disease Resistance Dev...mentioning
confidence: 99%